ofloxacin has been researched along with Vomiting in 5 studies
Ofloxacin: A synthetic fluoroquinolone antibacterial agent that inhibits the supercoiling activity of bacterial DNA GYRASE, halting DNA REPLICATION.
9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid : An oxazinoquinoline that is 2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinolin-7-one substituted by methyl, carboxy, fluoro, and 4-methylpiperazin-1-yl groups at positions 3, 6, 9, and 10, respectively.
ofloxacin : A racemate comprising equimolar amounts of levofloxacin and dextrofloxacin. It is a synthetic fluoroquinolone antibacterial agent which inhibits the supercoiling activity of bacterial DNA gyrase, halting DNA replication.
Vomiting: The forcible expulsion of the contents of the STOMACH through the MOUTH.
Excerpt | Relevance | Reference |
---|---|---|
" Nausea, vomiting, and diarrhoea were the most frequently reported adverse events." | 2.74 | Efficacy and safety of tigecycline versus levofloxacin for community-acquired pneumonia. ( Calistru, PI; Castaing, N; Chernyak, V; Cooper, CA; Dartois, N; Gandjini, H; Milutinovic, S; Strausz, J; Tanaseanu, C; Zolubas, M, 2009) |
"Clarithromycin resistance was indirectly assessed by the (13)C-urea breath test, with a post-treatment value cut-off point at 15." | 2.73 | Levofloxacin-containing triple therapy to eradicate the persistent H. pylori after a failed conventional triple therapy. ( Chang, WL; Chen, WY; Cheng, HC; Sheu, BS; Wu, JJ; Yang, HB, 2007) |
" The study indicates that ofloxacin is a safe and effective agent in the treatment of various infections." | 1.27 | Clinical safety and efficacy of ofloxacin. ( Concia, E; Grossi, P; Malfitano, A; Marone, P; Perversi, L, 1988) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (20.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (80.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Tanaseanu, C | 1 |
Milutinovic, S | 1 |
Calistru, PI | 1 |
Strausz, J | 1 |
Zolubas, M | 1 |
Chernyak, V | 1 |
Dartois, N | 1 |
Castaing, N | 1 |
Gandjini, H | 1 |
Cooper, CA | 1 |
Cheng, HC | 1 |
Chang, WL | 1 |
Chen, WY | 1 |
Yang, HB | 1 |
Wu, JJ | 1 |
Sheu, BS | 1 |
Flannery, MT | 1 |
Le, M | 1 |
Altus, P | 1 |
Stahlmann, R | 1 |
Marone, P | 1 |
Concia, E | 1 |
Grossi, P | 1 |
Malfitano, A | 1 |
Perversi, L | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
A Phase 3, Multicenter, Randomized, Double-Blind, Comparative Study Of The Efficacy And Safety Of Intravenous Tigecycline Vs Intravenous Levofloxacin To Treat Subjects Hospitalized With Community-Acquired Pneumonia[NCT00081575] | Phase 3 | 434 participants (Actual) | Interventional | 2004-01-31 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
2 trials available for ofloxacin and Vomiting
Article | Year |
---|---|
Efficacy and safety of tigecycline versus levofloxacin for community-acquired pneumonia.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Community-Acquired Infections; Diarrhea; Dose-Respon | 2009 |
Levofloxacin-containing triple therapy to eradicate the persistent H. pylori after a failed conventional triple therapy.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; | 2007 |
3 other studies available for ofloxacin and Vomiting
Article | Year |
---|---|
Endocarditis due to Salmonella.
Topics: Aged; Anti-Infective Agents; Cardiac Catheterization; Ceftriaxone; Cephalosporins; Combined Modality | 2001 |
Clinical toxicological aspects of fluoroquinolones.
Topics: Anti-Infective Agents; Bacterial Infections; Cardiovascular Diseases; Central Nervous System Disease | 2002 |
Clinical safety and efficacy of ofloxacin.
Topics: Adult; Aged; Aged, 80 and over; Bacterial Infections; Drug Evaluation; Female; Humans; Male; Middle | 1988 |